The Value of Source Data Verification in a Cancer Clinical Trial

Open Access

Peer-reviewed

Research Article

Catrin Tudur Smith ,

* E-mail: cat1@liv.ac.uk

Affiliation Department of Biostatistics, University of Liverpool, Liverpool, United Kingdom
⨯
Deborah D. Stocken,

Affiliation Birmingham Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom
⨯
Janet Dunn,

Affiliation Warwick Clinical Trials Unit, University of Warwick, Coventry, United Kingdom
⨯
Trevor Cox,

Affiliation Cancer Research UK Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, United Kingdom
⨯
Paula Ghaneh,

Affiliation Cancer Research UK Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, United Kingdom
⨯
David Cunningham,

Affiliation Department of Medicine, Royal Marsden Hospital, Sutton, Surrey, United Kingdom
⨯
John P. Neoptolemos

Affiliation Cancer Research UK Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, United Kingdom
⨯

Reader Comments (0)

Clinical trials
Is the Subject Area "Clinical trials" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Computed axial tomography
Is the Subject Area "Computed axial tomography" applicable to this article?

Thanks for your feedback.
Phase III clinical investigation
Is the Subject Area "Phase III clinical investigation" applicable to this article?

Thanks for your feedback.
Safety studies
Is the Subject Area "Safety studies" applicable to this article?

Thanks for your feedback.
Statistical data
Is the Subject Area "Statistical data" applicable to this article?

Thanks for your feedback.
Quality assurance
Is the Subject Area "Quality assurance" applicable to this article?

Thanks for your feedback.